163 related articles for article (PubMed ID: 37469759)
21. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G
Front Immunol; 2023; 14():1091218. PubMed ID: 36969232
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
Zhang S; Zhang W; Zhang J
Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208
[TBL] [Abstract][Full Text] [Related]
23. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
Front Immunol; 2022; 13():969034. PubMed ID: 36466881
[TBL] [Abstract][Full Text] [Related]
24. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
25. Mast cell marker gene signature in head and neck squamous cell carcinoma.
Cai Z; Tang B; Chen L; Lei W
BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
[TBL] [Abstract][Full Text] [Related]
26.
Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
[TBL] [Abstract][Full Text] [Related]
27. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
28. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
30. Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses.
Huang ZD; Liu ZZ; Liu YY; Fu YC; Lin LL; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():791621. PubMed ID: 35003112
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
32. Exploration of a predictive model based on genes associated with fatty acid metabolism and clinical treatment for head and neck squamous cell carcinoma.
Yuan Z; Huang J; Teh BM; Hu S; Hu Y; Shen Y
J Clin Lab Anal; 2022 Nov; 36(11):e24722. PubMed ID: 36181275
[TBL] [Abstract][Full Text] [Related]
33. Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
Wang X; Cao K; Guo E; Mao X; Guo L; Zhang C; Guo J; Wang G; Yang X; Sun J; Miao S
Front Immunol; 2021; 12():658631. PubMed ID: 33995377
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
35. A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma.
Huan C; Gao J
Math Biosci Eng; 2022 Aug; 19(12):12127-12145. PubMed ID: 36653989
[TBL] [Abstract][Full Text] [Related]
36. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
Li Q; Chen W; Li Q; Mao J; Chen X
Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
[TBL] [Abstract][Full Text] [Related]
37. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
[TBL] [Abstract][Full Text] [Related]
38. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract][Full Text] [Related]
39. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
40. Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.
Guo Q; Lu T; Xu H; Luo Q; Liu Z; Jiang S; Pan J; Lin S; Lin M; Guo F
Cancer Rep (Hoboken); 2023 May; 6(5):e1808. PubMed ID: 37092360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
